CapyFin

Calendar Reports Pricing

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Castle Biosciences Fiscal Q2 2019 Earnings Report | CapyFin

Castle Biosciences

CSTL · NASDAQ🇺🇸

Overview Earnings

Dividends Seasonality Metrics

Q4 2025 -7.32%Q3 2025 +21.77%Q2 2025 +32.36%Q1 2025 -11.69%Q4 2024 -14.24%Q3 2024 -6.03%Q2 2024 +11.76%Q1 2024 +10.49%Q4 2023 -28.02%Q3 2023 +14.52%Q2 2023 +12.26%Q1 2023 -0.23%Q4 2022 -7.67%Q3 2022 -6.00%Q2 2022 +0.26%Q1 2022 -4.11%Q4 2021 +4.50%Q3 2021 -7.24%Q2 2021 -4.86%Q1 2021 -9.55%Q4 2020 -9.94%Q3 2020 -3.27%Q2 2020 +0.12%Q1 2019 +17.08%Q1 2020 +17.08%Q1 2018 -1.53%Q4 2019 -1.53%Q3 2018 +19.99%Q3 2019 +18.16%Q2 2018 -6.95%Q2 2019 -6.95%Q4 2018 -6.95%

Sep 03, 2019

•

Jun 30, 2019

Castle Biosciences Q2 2019 Earnings Report

Previous year: $3.98M

Previous year: -$2.62

DecisionDx-Melanoma

Previous year: $2.65M

Cash and Equivalents

Previous year: $5.21M

Previous year: -$7.39M

Castle Biosciences

Unlock previous datapoints

Castle Biosciences

Unlock previous datapoints

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Castle Biosciences